The Stanford Neuro-Oncology Program Adult Clinical Trials

18F FPPRGD2 Positron Emission Tomography/Computed Tomography in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy
PI: Sanjiv Sam Gambhir NCT01806675

Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma
PI: Lawrence Recht NCT01977677

A Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain Treated With Nivolumab in Combination With Ipilimumab Followed by Nivolumab by itself
PI: Reena Thomas NCT02320058

Phase III Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
PI: Reena Thomas NCT02546102

Study of REGN2810 (Anti-PD-1) in Patients with Advanced Malignancies
PI: Seema Nagpal NCT02383212

A Phase III, Pivotal Trial of VB-111 plus Bevacizumab vs Bevacizumab in Patients with Recurrent Glioblastoma (GLOBE)
PI: Seema Nagpal NCT02511405

Phase II/III Randomized Study of Toca 511 & Toca FC Versus SOC in Subjects Undergoing Surgery for Recurrent GBM/AA
PI: Seema Nagpal NCT02414165

Phase II Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung CA / Metastatic Breast CA
PI: Joel Neal NCT02312622

A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients with ALK-Positive NSCLC Metastatic to the Brain and/or to Leptomeninges
PI: Joel Neal NCT02336451

Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients with Brain Metastases
PI: Scott Soltys NCT02360215

Phase Ib/II, Multicenter, Open-label Study of ACP-196 in Subjects with Recurrent Glioblastoma Multiforme (GBM)
PI: Lawrence Recht NCT02586857

Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas
PI: Lawrence Recht NCT01880749

Pilot PET/MRI After Bevacizumab Administration in Glioblastoma Multiforme
PI: Lawrence Recht

Pilot MR Imaging of Inflammatory Responses in Central Nervous System with Ferumoxytol-enhanced MRI
PI: Mike Iv